Hot signal

Submit
Hot signal
Guidelines for border management measures to protect health and ensure the availability of goods and essential services

Guidelines for border management measures to protect health and ensure the availability of goods and essential services

EUROPEAN COMMISSION Brussels, 16.3.2020 C(2020) 1753 final COVID-19 Guidelines for border management measures to protect health and ensure the availability of goods and essential...
Permission for parallel imports from the past has ensured the availability of oncology medicine in Bulgaria

Permission for parallel imports from the past has ensured the availability of oncology medicine in Bulgaria

Suspended imports are the cause of the lack of a cure for breast cancer with the active ingredient tamoxifen 10 mg. The first signal on the BAMPTD platform was received on 12 February 2020 by a...
Permission for parallel imports from the past has ensured the availability of oncology medicine in our country

Permission for parallel imports from the past has ensured the availability of oncology medicine in our country

Encouraging the import of medicines will ensure patient access, BAMPTD stated during the 2019 Capital Innovation Almanac of Healthcare Innovation Conference The first platform for drug shortage...

Our Goals

To generate savings on public and private funds for medicines.

To inform the patients and healthcare professionals about the benefits of parallel distribution of medicines.

To work through the activities of his members to provide access to missing medicines on the Bulgarian market.

To provide conditions for fast delivery of medicines at a lower price to Bulgarian patients.

To promotes and develop good practices and high quality standards in parallel distribution of medicines.

Bulgarian Association for Medicines Parallel Trade Development

The Bulgarian Association for Medicines Parallel Trade Development was established in November 2013 in Sofia.

The members of the Bulgarian Association for the Development of Parallel Drug Marketing are also members of the European Association of Euro-pharmaceutical Companies (EAEPC), which is the European Commission's regulated partner advocating the idea of parallel drug trade in the EU. EAEPC brings together more than 70 parallel drug dealers across 20 European Economic Area (EEA) countries.